NVAX (STOCKS)
Novavax Inc
$8.980100
+0.230100 (+2.63%)
Prev close: $8.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John C.s Jacobs
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,545.09M
- Employees
- 1,992
- P/E (TTM)
- 4.95
- P/B (TTM)
- -9.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
2
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.25 | $-1.21 | -0.0400 | -3.31% |
|
Jun 2025 (Q2)
|
$0.62 | $-0.09 | +0.7052 | +827.70% |
|
Mar 2025 (Q1)
|
$2.93 | $0.72 | +2.2099 | +306.89% |
|
Dec 2024 (Q4)
|
$-0.83 | $-0.52 | -0.3057 | -58.31% |
Financial Statements
| Revenues | $1.06B |
| Benefits Costs and Expenses | $713.97M |
| Cost Of Revenue | $87.60M |
| Costs And Expenses | $757.17M |
| Gross Profit | $977.05M |
| Operating Expenses | $669.56M |
| Selling, General, and Administrative Expenses | $201.70M |
| Depreciation and Amortization | $35.01M |
| Research and Development | $370.82M |
| Operating Income/Loss | $307.49M |
| Income/Loss From Continuing Operations After Tax | $341.75M |
| Income/Loss From Continuing Operations Before Tax | $350.68M |
| Income Tax Expense/Benefit | $8.94M |
| Net Income/Loss | $341.75M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $341.75M |
| Net Income/Loss Available To Common Stockholders, Basic | $341.75M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.10 |
| Diluted Earnings Per Share | $1.78 |
| Basic Average Shares | 326,593,000 |
| Diluted Average Shares | 342,467,000 |
| Assets | $1.18B |
| Current Assets | $974.59M |
| Inventory | $13.51M |
| Other Current Assets | $961.08M |
| Noncurrent Assets | $205.30M |
| Fixed Assets | $49.12M |
| Other Non-current Assets | $156.18M |
| Liabilities | $1.34B |
| Current Liabilities | $429.87M |
| Accounts Payable | $15.23M |
| Other Current Liabilities | $414.64M |
| Noncurrent Liabilities | $906.69M |
| Equity | -$156.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$156.67M |
| Liabilities And Equity | $1.18B |
| Net Cash Flow From Operating Activities | -$378.32M |
| Net Cash Flow From Operating Activities, Continuing | -$378.32M |
| Net Cash Flow From Investing Activities | $45.26M |
| Net Cash Flow From Investing Activities, Continuing | $45.26M |
| Net Cash Flow From Financing Activities | $30.92M |
| Net Cash Flow From Financing Activities, Continuing | $30.92M |
| Exchange Gains/Losses | -$3.08M |
| Net Cash Flow | -$305.23M |
| Net Cash Flow, Continuing | -$302.15M |
| Comprehensive Income/Loss | $336.40M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $336.40M |
| Other Comprehensive Income/Loss | $336.40M |
| Other Comprehensive Income/Loss Attributable To Parent | -$5.34M |